Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
Matthew T. Campbell(The University of Texas MD Anderson Cancer Center), Padmanee Sharma(The University of Texas MD Anderson Cancer Center)
Cited by 60
Related Papers
The Next Decade of Immune Checkpoint Therapy
|Cancer Discovery|2021|739
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer
|Nature Communications|2024|18
Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti–PD-1 therapy
|Science Advances|2025|1